Total Funding
73
56
Total FundingPost-IPO Debt raised
Growth Score 73 in past quarter
-16 pts
Heat Score 56 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
47880
Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.
Judy P. Ways: Vice President, Regulatory Affairs and Quality AssurancePast Role: MedImmune, VP of Regulatory Affairs
Cory Anderson: VP Clinical Affairs and Medical OperationsPast Role: Accuitive Medical Ventures, Principal
About the Company
Neuronetics is a medical technology company. They develop non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. They specialize in providing therapy for mental health.